Thermo Fisher Scientific Inc. (TMO)
| Market Cap | 193.99B |
| Revenue (ttm) | 42.88B |
| Net Income (ttm) | 6.34B |
| Shares Out | 377.26M |
| EPS (ttm) | 16.53 |
| PE Ratio | 31.11 |
| Forward PE | 22.04 |
| Dividend | $1.72 (0.33%) |
| Ex-Dividend Date | Mar 14, 2025 |
| Volume | 1,864,063 |
| Open | 525.18 |
| Previous Close | 526.80 |
| Day's Range | 509.41 - 526.21 |
| 52-Week Range | 493.30 - 627.88 |
| Beta | 0.79 |
| Analysts | Strong Buy |
| Price Target | 652.65 (+26.93%) |
| Earnings Date | Apr 23, 2025 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial StatementsAnalyst Forecast
According to 20 analysts, the average rating for TMO stock is "Strong Buy." The 12-month stock price forecast is $652.65, which is an increase of 26.93% from the latest price.
News
Buy Two Ideal March 'Safer' Dividend Dogs Of 34 Barron's 2025 Pro-Picks
Barron's New-Year (NY) Roundtable (RT) selections published in three issues 1/13-27/2025, listed 34 dividend picks as the best of 2025. Analysts predict top picks like AdvanSix, Applied Materials, and...
Thermo Fisher Scientific: Strong Q4, Strategic M&A, And Poised For Growth In Life Sciences
Thermo Fisher Scientific's Q4'24 and FY'24 results exceeded expectations, with revenue and profitability growing, positioning it for a potential 12% IRR long-term. Strong capital allocation, including...
Thermo Fisher Scientific Inc. (TMO) TD Cowen 45th Annual Health Care Conference - (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO) TD Cowen 45th Annual Health Care Conference Call March 3, 2025 9:10 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer C...
Trian Comments on Solventum's Sale of its Purification & Filtration Business
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns ~5% of Solventum Corporation (NYSE: SOLV) (“Solventum” or the “Company”) and is the Company's...
Thermo Fisher Scientific Launches CorEvitas Clinical Registry and Biorepository in Systemic Lupus Erythematosus
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus Registry.
Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion
Contract drug manufacturer Thermo Fisher Scientific said on Tuesday it will buy Solventum's purification and filtration business for about $4.1 billion.
Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B
Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for...
Thermo Fisher Scientific to Acquire Solventum's Purification and Filtration Business
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreem...
Thermo Fisher Scientific to Present at TD Cowen 45th Annual Health Care Conference on March 3, 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will pr...
Final Trades: Exxon Mobil, Thermo Fisher and Cheniere Energy
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Increases Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher Scientific Elects New Director to Board
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective Feb...
Thermo Fisher Scientific's New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses...
Laboratory Supplies Market Analysis 2022-2024 and Forecast 2025-2030, Featuring Profiles of Key Players - Th. Geyer, Thermo Fisher, Spectrum Chemical Manufacturing Corp., Ing.
Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Laboratory Supplies Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The global laboratory supplies mark...
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Alopecia Areata
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.
Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 10-year virtual power purchasing agreement (VPPA) with international ...
Thermo Fisher Scientific: Finally Ready For A Breakout? (Upgrade)
Thermo Fisher returned to growth in 4Q 2024 across all segments, and 2025 EPS growth is projected at 6.6% supported by margin expansion. Despite rich industry valuations, Thermo trades at a discount t...
Thermo Fisher Stock Surges as Medical Device Maker's Results Top Estimates
Shares of Thermo Fisher Scientific (TMO) rose Thursday after the medical device maker's fourth-quarter results topped analysts' estimates.
Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO) Q4 2024 Earnings Conference Call January 30, 2025 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, P...
Thermo Fisher beats quarterly estimates on strong demand for its tools and services
Thermo Fisher Scientific on Thursday beat Wall Street estimates for fourth-quarter profit and revenue, helped by improved demand for its products and services used in developing therapies.
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2024 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended Decembe...
Biologicals Is The Future In Thermo Fisher: Buy Rating
Thermo Fisher Scientific is poised for growth in 2025, driven by aging demographics, higher healthcare spending, and demand for innovative biological medicines. TMO's diverse revenue streams, includin...
Lyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
WATERTOWN, Mass.--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced a strategic collaboration with Thermo Fisher S...
Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly
The Investment Committee give you their top stocks to watch for the second half.
Thermo Fisher Scientific Inc. (TMO) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO) 43rd Annual J.P. Morgan Healthcare Conference Call January 14, 2025 11:15 AM ET Company Participants Marc Casper - Chief Executive Officer Conference Call Par...